Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

Clinical Performance of Two SARS-CoV-2 Serologic Assays | Synapse

May 12, 2020Open Access

Clinical Performance of Two SARS-CoV-2 Serologic Assays

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

The Abbott SARS-CoV-2 assay had fewer false positive and false negative results than the EI assay. However, diagnostic sensitivity was poor in both assays during the first 14 days of symptoms.

Leer artículo completoexternamente

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Tang et al. (Tue,) studied this question.

synapsesocial.com/papers/69de7d5f4838c5c0bab0bdcb https://doi.org/https://doi.org/10.1093/clinchem/hvaa120

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Evaluation of Nucleocapsid and Spike Protein-Based Enzyme-Linked Immunosorbent Assays for Detecting Antibodies against SARS-CoV-22020 · 650 citations
2Antibody responses to SARS-CoV-2 in patients with COVID-192020 · 3,117 citations
3Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma2020 · 2,425 citations
4Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein2020 · 9,118 citations
5Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study2020 · 3,377 citations